<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:47:49Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3595605" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:3595605</identifier><datestamp>2013-03-13</datestamp><setSpec>elsevierwt</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="brief-report">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Cell Rep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Cell Rep</journal-id>
      <journal-title-group>
        <journal-title>Cell Reports</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2211-1247</issn>
      <publisher>
        <publisher-name>Cell Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC3595605</article-id>
      <article-id pub-id-type="pmcid">PMC3595605</article-id>
      <article-id pub-id-type="pmc-uid">3595605</article-id>
      <article-id pub-id-type="pmid">23246003</article-id>
      <article-id pub-id-type="publisher-id">S2211-1247(12)00414-7</article-id>
      <article-id pub-id-type="doi">10.1016/j.celrep.2012.11.017</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Mutations in the Î²-Tubulin Gene <italic>TUBB5</italic> Cause Microcephaly with Structural Brain Abnormalities</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Breuss</surname>
            <given-names>Martin</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="fn1" ref-type="fn">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Heng</surname>
            <given-names>JulianÂ Ik-Tsen</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="fn1" ref-type="fn">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Poirier</surname>
            <given-names>Karine</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tian</surname>
            <given-names>Guoling</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jaglin</surname>
            <given-names>XavierÂ Hubert</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Qu</surname>
            <given-names>Zhengdong</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Braun</surname>
            <given-names>Andreas</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gstrein</surname>
            <given-names>Thomas</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ngo</surname>
            <given-names>Linh</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Haas</surname>
            <given-names>Matilda</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bahi-Buisson</surname>
            <given-names>Nadia</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Moutard</surname>
            <given-names>Marie-Laure</given-names>
          </name>
          <xref rid="aff5" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Passemard</surname>
            <given-names>Sandrine</given-names>
          </name>
          <xref rid="aff6" ref-type="aff">6</xref>
          <xref rid="aff7" ref-type="aff">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Verloes</surname>
            <given-names>Alain</given-names>
          </name>
          <xref rid="aff6" ref-type="aff">6</xref>
          <xref rid="aff7" ref-type="aff">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gressens</surname>
            <given-names>Pierre</given-names>
          </name>
          <xref rid="aff6" ref-type="aff">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Xie</surname>
            <given-names>Yunli</given-names>
          </name>
          <xref rid="aff8" ref-type="aff">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Robson</surname>
            <given-names>KathrynÂ J.H.</given-names>
          </name>
          <xref rid="aff9" ref-type="aff">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rani</surname>
            <given-names>DeepaÂ Selvi</given-names>
          </name>
          <xref rid="aff10" ref-type="aff">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Thangaraj</surname>
            <given-names>Kumarasamy</given-names>
          </name>
          <xref rid="aff10" ref-type="aff">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Clausen</surname>
            <given-names>Tim</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chelly</surname>
            <given-names>Jamel</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cowan</surname>
            <given-names>NicholasÂ Justin</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Keays</surname>
            <given-names>DavidÂ Anthony</given-names>
          </name>
          <email>keays@imp.ac.at</email>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="cor1" ref-type="corresp">â</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Institute of Molecular Pathology, Dr Bohr-Gasse, Vienna 1030, Austria</aff>
      <aff id="aff2"><label>2</label>Australian Regenerative Medicine Institute, Monash University, Clayton, Victoria 3800, Australia</aff>
      <aff id="aff3"><label>3</label>Institut Cochin; INSERM UnitÃ© 1016; CNRS UMR 8104; UniversitÃ© Paris Descartes, Sorbonne Paris CitÃ© Paris, France</aff>
      <aff id="aff4"><label>4</label>Department of Biochemistry and Molecular Pharmacology, New York University Medical Center, New York, NY 10016, USA</aff>
      <aff id="aff5"><label>5</label>Service de Neurologie Pediatrique, AP-HP, Hopital Trousseau, Paris, 75571, France</aff>
      <aff id="aff6"><label>6</label>INSERM UMR-676, Robert DebrÃ© Hospital, Paris, 75019, France</aff>
      <aff id="aff7"><label>7</label>Paris Diderot University, Department of GÃ©nÃ©tics, Robert DebrÃ© Hospital, Paris, France</aff>
      <aff id="aff8"><label>8</label>Institute of Molecular Biotechnology, Dr Bohr-Gasse 3, Vienna, Austria</aff>
      <aff id="aff9"><label>9</label>MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, United Kingdom</aff>
      <aff id="aff10"><label>10</label>Centre for Cellular and Molecular Biology, Habsiguda, Uppal Rd, Hyderabad 500 007, India</aff>
      <author-notes>
        <corresp id="cor1"><label>â</label>Corresponding author <email>keays@imp.ac.at</email></corresp>
        <fn id="fn1">
          <label>11</label>
          <p>These authors contributed equally to this work</p>
        </fn>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>27</day>
        <month>12</month>
        <year>2012</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.-->
      <pub-date pub-type="ppub">
        <day>27</day>
        <month>12</month>
        <year>2012</year>
      </pub-date>
      <volume>2</volume>
      <issue>6</issue>
      <fpage>1554</fpage>
      <lpage>1562</lpage>
      <history>
        <date date-type="received">
          <day>27</day>
          <month>4</month>
          <year>2012</year>
        </date>
        <date date-type="rev-recd">
          <day>18</day>
          <month>7</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>11</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2012 The Authors</copyright-statement>
        <copyright-year>2012</copyright-year>
        <license xlink:href="https://creativecommons.org/licenses/by-nc-nd/3.0/">
          <license-p>Open Access under <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/3.0/">CC BY-NC-ND 3.0</ext-link> license</license-p>
        </license>
      </permissions>
      <abstract>
        <title>Summary</title>
        <p>The formation of the mammalian cortex requires the generation, migration, and differentiation of neurons. The vital role that the microtubule cytoskeleton plays in these cellular processes is reflected by the discovery that mutations in various tubulin isotypes cause different neurodevelopmental diseases, including lissencephaly (<italic>TUBA1A</italic>), polymicrogyria (<italic>TUBA1A</italic>, <italic>TUBB2B</italic>, <italic>TUBB3</italic>), and an ocular motility disorder (<italic>TUBB3</italic>). Here, we show that <italic>Tubb5</italic> is expressed in neurogenic progenitors in the mouse and that its depletion inÂ vivo perturbs the cell cycle of progenitors and alters the position of migrating neurons. We report the occurrence of three microcephalic patients with structural brain abnormalities harboring de novo mutations in <italic>TUBB5</italic> (M299V, V353I, and E401K). These mutant proteins, which affect the chaperone-dependent assembly of tubulin heterodimers in different ways, disrupt neurogenic division and/or migration inÂ vivo. Our results provide insight into the functional repertoire of the tubulin gene family, specifically implicating <italic>TUBB5</italic> in embryonic neurogenesis and microcephaly.</p>
      </abstract>
      <abstract abstract-type="graphical">
        <sec>
          <title>Graphical Abstract</title>
          <p>
            <fig id="undfig1" position="anchor">
              <graphic xlink:href="fx1"/>
            </fig>
          </p>
        </sec>
        <sec>
          <title>Highlights</title>
          <p>âº The Î²-tubulin Tubb5 is highly expressed in the developing mouse and human cortex âº InÂ vivo knockdown of Tubb5 perturbs the cell cycle and alters neuronal positioning âº Mutations in <italic>TUBB5</italic> cause microcephaly with dysmorphic basal ganglia in humans âº <italic>TUBB5</italic> mutations affect chaperone-mediated tubulin folding in different ways</p>
        </sec>
      </abstract>
      <abstract abstract-type="teaser">
        <p>The formation of the cortex requires the generation, migration, and differentiation of neurons. While specific tubulin isotypes have been implicated in postmitotic events, those that mediate neurogenesis remain unknown. Here, Keays and colleagues report that mutations in the Î²-tubulin gene, <italic>TUBB5</italic>, cause microcephaly. They show that this gene is highly expressed in neuronal progenitors, and its depletion inÂ vivo perturbs the cell cycle and alters neuronal migration. This work provides insight into the functional repertoire of the tubulin gene family.</p>
      </abstract>
    </article-meta>
    <notes>
      <p>Published: December 13, 2012</p>
    </notes>
  </front>
  <body>
    <sec sec-type="intro" id="sec1">
      <title>Introduction</title>
      <p>The formation of the mammalian cortex, a complex multilayered structure, requires the birth of neurons in the ventricular and subventricular zones followed by phases of bipolar and multipolar migration before newly born neurons arrive at their final destination in the cortical plate (<xref rid="bib5" ref-type="bibr">Feng and Walsh, 2001</xref>). This sophisticated cellular journey relies on a myriad of intracellular and intercellular signaling factors that converge on the cytoskeleton (<xref rid="bib1" ref-type="bibr">Ayala etÂ al., 2007</xref>). The importance of the microtubule cytoskeleton in the sequential steps involved in migration and differentiation is reflected in the finding that mutations in various tubulin genes cause a range of structural brain abnormalities. Mutations in the Î±-tubulin subunit <italic>TUBA1A</italic> have been shown to result in lissencephaly (<xref rid="bib9" ref-type="bibr">Keays etÂ al., 2007</xref>); mutations in the Î²-tubulin subunit <italic>TUBB2B</italic> cause asymmetric polymicrogyria (<xref rid="bib8" ref-type="bibr">Jaglin etÂ al., 2009</xref>); and it has been shown that mutations in <italic>TUBB3</italic> cause an ocular motility disorder (<xref rid="bib21" ref-type="bibr">Tischfield etÂ al., 2010</xref>), as well as a broad range of cortical abnormalities (<xref rid="bib19" ref-type="bibr">Poirier etÂ al., 2010</xref>). Most recently, the tubulin genes <italic>TUBA1A</italic> and <italic>TUBB2B</italic> have also been implicated in autism spectrum disorders (<xref rid="bib15" ref-type="bibr">Neale etÂ al., 2012</xref>; <xref rid="bib18" ref-type="bibr">Pinto etÂ al., 2010</xref>). Together, these studies have implicated specific tubulin isotypes in postmitotic cellular events, but those isotypes that mediate the generation of neurons, a process that requires the assembly of microtubules into a highly organized mitotic spindle, remain unknown (<xref rid="bib16" ref-type="bibr">Ohnuma and Harris, 2003</xref>). Here, we set out to identify those tubulin genes required for cortical neurogenesis. We report that the Î²-tubulin gene <italic>TUBB5</italic> is highly expressed in the developing cortex and that mutations in this gene cause microcephaly, with a range of structural brain abnormalities that include dysmorphic basal ganglia, dysgenesis of the corpus callosum, brainstem hypoplasia, and focal polymicrogyria.</p>
    </sec>
    <sec id="sec2">
      <title>Results and Discussion</title>
      <sec id="sec2.1">
        <title><italic>Tubb5</italic> Is Expressed at High Levels in the Developing Brain</title>
        <p>We surveyed the expression of all known Î²-tubulin genes in theÂ developing mouse (E10.5, E12.5, E14.5, E16.5, P0) and human (gestational week [GW] 13, GW22) cortex by quantitative real-time PCR (<xref rid="bib2" ref-type="bibr">Braun etÂ al., 2010</xref>). We observed consistently high expression levels of <italic>Tubb2b</italic>, <italic>Tubb3,</italic> and <italic>Tubb5</italic>, with <italic>Tubb5</italic> the highest expressed isotype in the embryonic mouse brain (<xref rid="fig1" ref-type="fig">Figures 1</xref>A and 1B). We investigated the spatial expression of <italic>Tubb5</italic> by inÂ situ hybridization at embryonic day (E) 12.5, E14.5, and E16.5 (<xref rid="fig1" ref-type="fig">Figures 1</xref>Câ1H). This revealed robust expression throughout the developing cortex, particularly in the subventricular zone (SVZ) at E14.5, which was absent in sense controls (<xref rid="figs1" ref-type="fig">Figures S1</xref>AâS1C). Because there are no validated antibodies that are specific for <italic>Tubb5,</italic> we created a transgenic mouse line that drives enhanced green fluorescent protein (EGFP) from the endogenous <italic>Tubb5</italic> promoter to determine which cell types express <italic>Tubb5</italic> (<xref rid="figs1" ref-type="fig">Figures S1</xref>DâS1Q). This mouse recapitulated our inÂ situ hybridization results and demonstrated that <italic>Tubb5</italic> is expressed in radial glial cells (Pax6 positive), intermediate progenitors (Tbr2 positive), migrating neurons (Dcx positive), and postmitotic neurons (Tuj positive; <xref rid="fig1" ref-type="fig">Figures 1</xref>Iâ1X).</p>
      </sec>
      <sec id="sec2.2">
        <title>Depletion of <italic>Tubb5</italic> Perturbs the Progenitor Cell Cycle and the Migration of Neurons</title>
        <p>We investigated the effect of <italic>Tubb5</italic> depletion on cortical development in mice by employing a small hairpin RNA (shRNA) that targets its 3â²UTR. Following validation of this shRNA in Neuro-2a cells (<xref rid="figs2" ref-type="fig">FigureÂ S2</xref>A), we electroporated it into progenitor cells of the ventricular zone (VZ) at E14.5, together with a GFP expressing vector (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>A). Quantification of the fraction of GFP-positive cells that coexpress pH3 (mitotic index) after 36Â hr of knockdown revealed an increase in the percentage of these mitotic cells in the VZ/SVZ when <italic>Tubb5</italic> was depleted (nÂ = 6; pÂ &lt; 0.001). This effect could be rescued by codelivering a <italic>Tubb5</italic> expression construct that lacked the shRNA targeting sequence (<xref rid="fig2" ref-type="fig">Figures 2</xref>Bâ2D; <xref rid="figs2" ref-type="fig">Figures S2</xref>D and S2E; <xref rid="mmc1" ref-type="supplementary-material">Table S2</xref>) and replicated when employing an alternative shRNA (data not shown). Because mutations in <italic>Tuba1a</italic> have been shown to induce apoptosis, we studied cell survival by staining for cleaved caspase-3 at E16, following electroporation at E14.5 (<xref rid="bib4" ref-type="bibr">Edwards etÂ al., 2011</xref>). This revealed no statistically significant difference between conditions, but we cannot exclude the possibility of increased apoptosis following long-term depletion of <italic>Tubb5</italic> (<xref rid="figs2" ref-type="fig">Figures S2</xref>FâS2O). Next, we investigated the effect of <italic>Tubb5</italic> depletion on neuronal migration by electroporating our shRNA at E14.5 and harvesting embryos 72Â hr later (migration index). In comparison to controls, we observed a significant decrease in the percentage of GFP-labeled cells in the cortical plate (CP) when <italic>Tubb5</italic> was depleted, concomitant with an accumulation of cells within the VZ and intermediate zone (IZ) (n â¥ 5; VZ: pÂ &lt;Â 0.05; IZ: pÂ &lt; 0.05; CP: pÂ &lt; 0.01; <xref rid="fig2" ref-type="fig">Figures 2</xref>Eâ2G; <xref rid="figs2" ref-type="fig">Figures S2</xref>B and S2C; <xref rid="mmc1" ref-type="supplementary-material">Table S2</xref>). To assess whether <italic>Tubb5</italic> depletion affects the final positioning of neurons, we harvested brains at postnatal day (P) 17, following electroporation at E14.5. Quantification of the percentage of GFP positive cells in the six layers of the P17 cortex showed that <italic>Tubb5</italic> knockdown results in a long-term positioning defect (nÂ = 4; layer VI: pÂ &lt; 0.05; layers IIâIV: pÂ &lt;Â 0.01) (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>H). We conclude that <italic>Tubb5</italic> depletion perturbs the neurogenic cell cycle and alters the positioning of migrating neurons.</p>
      </sec>
      <sec id="sec2.3">
        <title>Mutations in <italic>TUBB5</italic> Cause Microcephaly in Humans</title>
        <p>On the basis of these results, we surmised that mutations in <italic>TUBB5</italic> might cause neurodevelopmental disease in humans. We therefore screened a panel of patients with a range of brain malformations, resulting in the identification of three unrelated microcephalic individuals harboring de novo mutations in <italic>TUBB5</italic> (M299V, V353I, and E401K) (<xref rid="figs3" ref-type="fig">Figures S3</xref>AâS3C). Each individual presented with microcephaly (with an orbitofrontal cortex [OFC] ranging from â2.5 SD to â4 SD), dysmorphic basal ganglia, corpus callosum abnormalities, and cognitive impairment with motor and language delay (<xref rid="tbl1" ref-type="table">Table 1</xref>; <xref rid="fig3" ref-type="fig">Figures 3</xref>Aâ3F; <xref rid="figs3" ref-type="fig">Figures S3</xref>E and S3F). Two of the patients (M299V and V353I) shared unusual white matter streaks with a radial orientation through the lenticular nucleus, as well as brainstem hypoplasia (<xref rid="fig3" ref-type="fig">Figures 3</xref>Aâ3F). The child harboring the V353I mutation originates from a family with a history of microcephaly (without mental retardation), raising the prospect that another genetic factor contributes to his disease. Sequencing of known microcephaly genes (<italic>MCPH1</italic>, <italic>CD5KRAP2</italic>, <italic>WDR62</italic>, <italic>ASPM</italic>) and the known disease causing tubulins (<italic>TUBA1A</italic>, <italic>TUBB2B,</italic> and <italic>TUBB3</italic>) did not identify any pathogenic variants in the patients described. A search of publicly available genomic databases showed that the M229V, V353I, and E401K mutations are not present in the general population. Moreover, screening of ethnically relevant controls (French/Caucasian, 238; Vietnamese, 115; Indian subcontinent, 252) failed to identify these variants. Homology analysis showed that these residues are highly conserved in all human Î²-tubulins and related tubulin isotypes from yeast to humans (<xref rid="figs3" ref-type="fig">FigureÂ S3</xref>D).</p>
      </sec>
      <sec id="sec2.4">
        <title>Functional Analysis of Disease-Causing Mutations</title>
        <p>We mapped the location of the affected residues onto the known structure of the Î±/Î² heterodimer (<xref rid="fig3" ref-type="fig">Figures 3</xref>Gâ3J). M299 lies in a loop following helix 9, with its side chain protruding into a deep hydrophobic pocket. V353 lies on the intradimer interface, whereas E401, which precedes helix 12, lies on the surface of the interdimer interface. This residue is in close proximity to a loop (Î±Î±98â104) that is critical for nucleotide binding (<xref rid="bib14" ref-type="bibr">LÃ¶we etÂ al., 2001</xref>) and that may be reoriented by substitution with a lysine residue. All three mutations have the potential to compromise either the complex chaperone-dependent reactions that are essential for tubulin heterodimer assembly or the dynamic behavior of microtubules (<xref rid="bib20" ref-type="bibr">Tian etÂ al., 2010</xref>). To address these issues, we monitored the expression and folding of the mutant proteins kinetically in rabbit reticulocyte lysate. Analysis of the products under denaturing conditions showed that the translation efficiency of all three mutants was similar to the wild-type control (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>K). However, analysis of the same reaction products under native conditions revealed quantitative and qualitative differences (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>L). The wild-type protein and V353I and M299V mutants produced the expected folding intermediates (CCT/Î², TBCD/Î², PFD/Î², and TBCA/Î²) (<xref rid="bib3" ref-type="bibr">Cowan and Lewis, 2001</xref>) before generating Î±/Î² heterodimers when chased with native bovine tubulin, but with a notable reduction in yield for the M299V mutation. In the case of the E401K mutation, the assembly pathway was arrested, with a conspicuous retention of the mutant polypeptide complexed with prefoldin (PFD) and the cytosolic chaperonin (CCT), and a dearth of native Î±/Î² heterodimers. We also examined the capacity of the TUBB5 mutants to incorporate into the microtubule network in Neuro-2a cells (<xref rid="fig3" ref-type="fig">Figures 3</xref>Mâ3X). Whereas the wild-type M299V and V353I proteins coassembled into interphase microtubules, we found that the E401K mutant protein failed to do so and was diffusely distributed throughout the cytoplasm. We conclude that the V353I and M299V mutations do not affect the ability of the mutant polypeptides to assemble into heterodimers and incorporate into microtubules, although the yield in the case of M299V may be compromised. In contrast, the E401K mutation results in a severe ablation of TUBB5 function, as it results in a massive failure of chaperone-mediated heterodimer assembly with a consequent inability of the mutant protein to incorporate into microtubules.</p>
      </sec>
      <sec id="sec2.5">
        <title>Effects of Human Mutations on Murine Neuronal Development</title>
        <p>To examine the effect of these mutations inÂ vivo, we used in utero electroporation to overexpress the mutant forms of <italic>Tubb5</italic> in the developing mouse brain. While overexpression of wild-type <italic>Tubb5</italic> had no effect on the mitotic index (nÂ = 5; p &gt; 0.5), we found a large increase in the percentage of GFP/pH3-colabeled cells in the VZ and SVZ when expressing the E401K and V353I mutants, similar to our <italic>Tubb5</italic> depletion experiments (nÂ = 5; pÂ &lt; 0.001 for both mutants; <xref rid="fig4" ref-type="fig">Figures 4</xref>A, 4D, and 4E). Electroporation of the M299V expression construct also resulted in a modest increase in the mitotic index within the cortical germinal zone (VZÂ + SVZ), although this increase was not statistically significant (nÂ = 5; pÂ &gt;Â 0.05; <xref rid="fig4" ref-type="fig">Figures 4</xref>A and 4C). We also examined the migratory index following expression of the <italic>Tubb5</italic> mutants. In comparison to controls, we found that expression of all three mutants resulted in a significant increase in the percentage of GFP-positive cells in the IZ and a corresponding decrease in the CP that was most severe in the case of the V353I mutant (nÂ = 5; M299V: IZ: pÂ &lt; 0.001; CP: pÂ &lt; 0.01; V353I: VZ: pÂ &lt; 0.01; IZ: pÂ &lt;Â 0.001; CP: pÂ &lt; 0.001; E401K: IZ: pÂ &lt; 0.001; CP: pÂ &lt; 0.01; <xref rid="fig4" ref-type="fig">Figures 4</xref>B and 4Gâ4I). These changes were not observed upon overexpression of wild-type <italic>Tubb5</italic> alone (nÂ = 5; p &gt; 0.05; <xref rid="fig4" ref-type="fig">FigureÂ 4</xref>F). Analysis of neurons at P17 following the overexpression of <italic>Tubb5</italic> mutants revealed aberrant clusters of ectopic cellsÂ in deep layers of the cortex (<xref rid="figs4" ref-type="fig">FigureÂ S4</xref>). Quantification showed that in comparison to controls, this results in fewer cells in superficial layers of the cortex (n â¥ 2; M299V: IIâIV: pÂ &lt; 0.05; E401K: IIâIV: pÂ &lt; 0.001) and an accumulation of GFP-positive cells in the deeper layers (E401K: nÂ = 3; VI: pÂ &lt; 0.01), but this was not significant in the case of the V353I mutation (nÂ = 3; VI: p &gt; 0.05). This result demonstrates that the migratory defects described above have a long-term effect on neuronal position, and consequently on the structural architecture of the brain. Together, these data support our conclusion that the mutations are pathogenic, with an effect on both the generation and subsequent migration of neurons.</p>
        <p>The three mutations we identified (M299V, V353I, and E401K) are likely to act by different molecular mechanisms (<xref rid="bib23" ref-type="bibr">Walsh andÂ Engle, 2010</xref>). The impairment in heterodimer assembly observed in the case of the E401K and M299V mutations suggests that they act by loss-of-function; however, the marked phenotype that results from heterologous expression of all mutants inÂ vivo raises the prospect of a dominant-negative effect. It is conceivable that kinetically trapped E401K and M299V polypeptides have a deleterious effect on the entire chaperone-mediated tubulin folding and assembly pathway, while the V353I mutation may alter the dynamic properties of microtubules or compromise the binding of one or more essential microtubule associated proteins (<xref rid="bib11" ref-type="bibr">Kumar etÂ al., 2010</xref>; <xref rid="bib21" ref-type="bibr">Tischfield etÂ al., 2010</xref>; <xref rid="bib23" ref-type="bibr">Walsh and Engle, 2010</xref>). The underlying cellular pathology is likely to be equally as complex. We have shown that both knockdown of Tubb5 and overexpression of Tubb5 mutants result in a paradoxical increase in pH3 reactivity. There are a number of explanations for this unexpected result, which implies an increase in mitotic output. First, it is conceivable that there is an elongation of M-phase, which delays progression of the cell cycle and the generation of neurons (<xref rid="bib13" ref-type="bibr">Lizarraga etÂ al., 2010</xref>). Second, it is possible that hyperproliferating apical progenitors result in fewer intermediate progenitors, and consequently an overall reduction in postmitotic neurons (<xref rid="bib10" ref-type="bibr">Kim etÂ al., 2009</xref>). Third, M-phase arrest may, at a later point in time, result in increased apoptosis, accounting for the incongruity between our inÂ vivo pH3 results and the human phenotype. Further studies focused on the timing and output of the cell cycle will be necessary to establish which of the aforementioned mechanisms are responsible.</p>
        <p>It is apparent from this study that patients with mutations in <italic>TUBB5</italic> share structural brain abnormalities in common with the previously described tubulinopathies (<italic>TUBA1A</italic>, <italic>TUBB2B</italic>, <italic>TUBB3</italic>), including dysmorphic basal ganglia, abnormalities of the corpus callosum, and brainstem phenotypes (<xref rid="bib22" ref-type="bibr">Tischfield etÂ al., 2011</xref>). The distinguishing feature of <italic>TUBB5</italic>-associated disease is microcephaly, which we attribute to the high level ofÂ <italic>TUBB5</italic> expression in neuronal progenitors. This contrasts with <italic>TUBA1A</italic>, <italic>TUBB2B,</italic> and <italic>TUBB3,</italic> all of which are largely restricted in their expression to postmitotic neurons in the developing brain (<xref rid="bib6" ref-type="bibr">Gloster etÂ al., 1999</xref>; <xref rid="bib8" ref-type="bibr">Jaglin etÂ al., 2009</xref>; <xref rid="bib12" ref-type="bibr">Liu etÂ al., 2007</xref>). <italic>TUBB5</italic> may have a specific function in mitotically active cells, or alternatively make a critical contribution to the supply of tubulin heterodimers. In either event, our work provides insightÂ into the functional repertoire of the tubulin gene family, specifically implicating <italic>TUBB5</italic> in embryonic neurogenesis and microcephaly.</p>
      </sec>
    </sec>
    <sec sec-type="methods" id="sec3">
      <title>Experimental Procedures</title>
      <sec id="sec3.1">
        <title>Animals</title>
        <p>Animals were maintained within the animal research laboratories of the Institute of Molecular Pathology and Monash University on a 12:12 light:dark cycle with food available ad libitum. All procedures were performed in accordance with existing animal licenses and guidelines (M58-006093-2011-13 B).</p>
      </sec>
      <sec id="sec3.2">
        <title>Generation of Tg(Tubb5-EGFP) Mice</title>
        <p>The Red/ET system (<italic>K001</italic>, Gene Bridges) was employed to replace the endogenous <italic>Tubb5</italic> (<italic>RP24-330C1</italic>) with EGFP. Following generation of the construct, we proceeded with pronuclear injection and PCR screening to confirm germline transmission before immunostaining.</p>
      </sec>
      <sec id="sec3.3">
        <title>In Situ Hybridization</title>
        <p>C57/BL6 embryos were harvested, postfixed in 4% paraformaldehyde (PFA),Â dehydrated in a pressure- and temperature-controlled environment, embedded in paraffin, and sectioned (14Â Î¼m). We then proceeded with inÂ situ hybridization as previously described (<xref rid="bib2" ref-type="bibr">Braun etÂ al., 2010</xref>).</p>
      </sec>
      <sec id="sec3.4">
        <title>Real-Time Quantitative PCR</title>
        <p>Embryonic, postnatal, and adult tissues (C57/BL6) were dissected and snapÂ frozen before mRNA extraction and reverse transcription. Quantitative real-time PCR followed employing exon spanning primers and three internal control genes. For human studies, fetal brain cDNA was obtained from Yorkshire Biosciences.</p>
      </sec>
      <sec id="sec3.5">
        <title>In Utero Electroporation Experiments</title>
        <p>Sequence-verified constructs for wild-type and mutant versions of <italic>Tubb5</italic> were cloned into pCIG2. shRNAs optimized for specific knockdown of <italic>Tubb5</italic> were cloned into the pSuper vector system. In utero electroporation, cryosectioning, and immunostaining were performed as previously described (<xref rid="bib7" ref-type="bibr">Heng etÂ al., 2008</xref>; <xref rid="bib17" ref-type="bibr">Pacary etÂ al., 2011</xref>). Cell counting was performed blind to the condition on representative fields of sections of electroporated brains using ImageJ software.</p>
      </sec>
      <sec id="sec3.6">
        <title>Biochemical and Cellular Studies</title>
        <p>Plasmids encoding the <italic>Tubb5</italic> mutants were expressed in rabbit reticulocyte lysate (Promega) as described (<xref rid="bib20" ref-type="bibr">Tian etÂ al., 2010</xref>) before analysis on native polyacrylamide gels. For cellular studies, FLAG-tagged TUBB5 DNA constructs were transfected into Neuro-2a cells before immunostaining with anÂ anti-Î±-tubulin antibody (Sigma, T6199-200UL) and an anti-FLAG antibody (Abcam, ab1162).</p>
      </sec>
      <sec id="sec3.7">
        <title>Human Studies</title>
        <p>We obtained DNA and informed consent according to the guidelines of local institutional review boards at Cochin Hospital and INSERM. <italic>TUBB5</italic> was screened in 120 individuals with sporadic structural brain abnormalities that included lissencephaly, polymicrogyria, microcephaly, and nodular heterotopia. These patients had previously been screened for mutations in the known disease-causing tubulin genes (<italic>TUBA1A, TUBB2B, TUBB3</italic>), and (depending on their phenotype) for other pathogenic genes (e.g., <italic>DCX, LIS1, FLNA</italic>). Following the identification of de novo mutations in <italic>TUBB5,</italic> parental relationships were confirmed using a suite of microsatellite markers.</p>
      </sec>
      <sec id="sec3.8">
        <title>Statistics</title>
        <p>Statistical analysis was performed with the GraphPad Prism 5 software package. For experiments with two conditions, we performed a Studentâs tÂ test. For experiments with multiple conditions, we used a one-way ANOVA followed by Bonferroni multiple comparison test.</p>
        <p>For additional details, please see the <xref rid="dtbox1" ref-type="boxed-text">Extended Experimental Procedures</xref>.</p>
        <p>
          <boxed-text id="dtbox1">
            <label>Extended Experimental Procedures</label>
            <sec id="dtbox1sec1">
              <title>Generation and Immunostaining of Tg(Tubb5-EGFP) Mice</title>
              <p>A Bacterial Artificial Chromosome (BAC; <italic>RP24-330C1</italic>) containing the <italic>Tubb5</italic> gene was first validated by restriction enzyme (FspI) and PCR analysis. We employed high fidelity PCR to amplify a GFP-FRT-NEO-FRT cassette flanked by 60 base pair sequences homologous to the <italic>Tubb5</italic> locus (see <xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>), and employed the Red/ET system (<italic>K001</italic>, Gene Bridges) to replace the endogenous <italic>Tubb5</italic> gene. Following excision of the neomycin resistance cassette with a 707-FLPe plasmid (<italic>A104</italic>, Gene Bridges), we proceeded with pronuclear injection, and PCR screening for genomic incorporation (see <xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>). Embryos were harvested at E12.5, E14.5 and E16.5 and fixed in 4% PFA overnight before dehydration in 30% sucrose overnight, embedding and sectioning (12Â Î¼m). Sections were incubated with the primary antibody overnight in 0.1%â0.3% triton/PBS with 2% of the appropriate serum at the following concentrations: Dcx (1:100, Santa Cruz), Tuj1 (1:1000, Covance), Tbr2 (1:200, Abcam), Pax6 (1:300, Covance). For Tbr2 and Pax6 staining we performed antigen retrieval with citrate buffer (0.01M, pH6.0); slides were heated from room temperature to 90Â°C in a water bath and then placed at to room temperature for 20Â min prior to incubation with the primary antibody overnight (14-16Â hr) at 4Â°C. The next day, sections were washed 3 times in PBS (5Â min each), before application of a species specific secondary antibody (Molecular Probes) for 1Â hr in 0.1%â0.3% triton/PBS. Sections were then mounted in VectaShield Mounting Medium (hard set with DAPI). Microscopy was performed on a Zeiss LSM 710, with the exception of the low magnification images of the Tg(Tubb5-EGFP) embryos that were captured with a Mirax slide scanner (Zeiss).</p>
            </sec>
            <sec id="dtbox1sec2">
              <title>In Situ Hybridization</title>
              <p>C57/BL6 embryos were harvested at E12.5, E14.5 and E16.5, post-fixed in 4% PFA, dehydrated in a pressure and temperature controlled environment, embedded in paraffin and sectioned (14Â Î¼m). Prior to inÂ situ hybridization these sections were de-paraffined employing standard protocols. A 165 base pair probe for inÂ situ hybridization was amplified by PCR (see <xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>), cloned into a pCRII-TOPO vector (Invitrogen), the vector linearized and an inÂ vitro transcription reaction conducted with a DIG labeling mix (Roche). Sections were post-fixed with PFA (4% for 10mins) before pretreatment with proteinase K (1Â Î¼g/ml for 10mins), and acetylated (0.1M triethanolamine, 0.25% acetic anhydride, 15mins). Following a prehybridization step (4hrs at RT) in hybridization buffer (10mM Tris pH7.5, 600mM NaCl, 1mM EDTA, 0.25% SDS, 10% Dextran Sulfate, 1x Denhartdtâs, 200Â Î¼g/ml yeast tRNA) the denatured probe was applied, and hybridized overnight at 60Â°C in a custom-built hybridization chamber. Post hybridization washes and RNase treatment were performed as previously described (<xref rid="bib24" ref-type="bibr">Murtaugh etÂ al., 1999</xref>). Staining was visualized by incubating sections with an alkaline phosphatase conjugated digoxigenin antibody (1:2000, 4Â°C, overnight), followed by the application of BM-Purple AP.</p>
            </sec>
            <sec id="dtbox1sec3">
              <title>Real-Time Quantitative PCR</title>
              <p>Embryonic (E10.5, E12.5, E14.5, E16.5, E18.5), postnatal (P0, P6) and adult (8Â weeks) tissues (C57/BL6) were dissected and snap frozen, before mRNA extraction employing either an RNeasy lipid tissue kit or an RNeasy fibrous tissue kit. RNA was extracted from three independent samples at the same developmental time point, brain region or organ, quantified and then pooled for reverse transcription (SuperScript III First-Strand Synthesis System, Invitrogen, 18080-051). For human studies fetal brain cDNA was obtained from Biochain (C1244051, C1244035). For quantitative real-time PCR we designed intron-spanning primers employing the Primer3 program, and undertook BLAST searches to confirm their specificity (see <xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>). Following efficiency testing, we did quantitative real-time PCR with SYBR green on a Bio-Rad Cycler together with negative controls. To maximize the accuracy of our real-time PCR experiments we used three internal control genes for our mouse (Pgk1, Tfrc, and Hprt) and human studies (HPRT, PGK1, TBP), and calculated the geometric mean as previously described (<xref rid="bib25" ref-type="bibr">Vandesompele etÂ al., 2002</xref>).</p>
            </sec>
            <sec id="dtbox1sec4">
              <title>Generation and Cellular Validation of shRNA Constructs</title>
              <p>Short hairpin RNAs for <italic>Tubb5</italic> knockdown were cloned into the pSuper vector system according to the manufacturerâs instructions (<italic>VEC-pBS-0002</italic>). The efficiency of the short hairpin (see <xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>) was assessed by quantitative real-time PCR 36 and 72Â hr post transfection of the constructs with Lipofectamine 2000 (Invitrogen, 11668-027) into Neuro-2a cells. RNA extraction (Roche, High Pure RNA Isolation Kit) and cDNA synthesis (Roche, Expand Reverse Transcriptase) were performed in accordance with the manufacturersâ protocol. Quantitative real-time PCR utilized the SYBR green dye on a Roche LightCycler. <italic>Tubb5</italic> expression levels were normalized relative to <italic>Hprt</italic> (see <xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>).</p>
            </sec>
            <sec id="dtbox1sec5">
              <title>Cellular Studies</title>
              <p>Neuro-2a cells were kept under standard cell culture conditions in DMEM supplemented with 10% FBS (Sigma, F7524), 1% L-Glu (Sigma, G7513) and 1% PenStrep (Sigma, P0781). DNA constructs were transfected with Oligofectamine (Invitrogen, 12252-011) according to the manufacturerâs protocol. Immunostaining employing an anti-Î±-tubulin antibody (Sigma, T6199-200UL) and anti-FLAG antibody (Abcam, ab1162) was performed as previously described (<xref rid="bib9" ref-type="bibr">Keays etÂ al., 2007</xref>).</p>
            </sec>
            <sec id="dtbox1sec6">
              <title>In Utero Electroporation Experiments</title>
              <p>Sequence-verified expression constructs for wild-type and mutant versions of <italic>Tubb5</italic> were cloned by PCR amplification of the coding sequence followed by ligation into the EcoRI/XhoI site of pCIG2. In utero electroporation was performed as described previously (<xref rid="bib7" ref-type="bibr">Heng etÂ al., 2008</xref>; <xref rid="bib17" ref-type="bibr">Pacary etÂ al., 2011</xref>). High-quality, low-endotoxin plasmid preparations (QIAGEN) of GFP expression vector (pCIG2) and shRNA vectors were injected at 1Â Î¼g/Î¼l for each plasmid, together with Fast Green (0.05%, Sigma). Electroporation of telencephalic vesicles of DNA-injected embryos was achieved using platinum electrodes (Nepagene) connected to an electroporator (ECM830, BTX) to deliver five pulses of 30Â V (50Â ms duration) at 1Â s intervals. Control electroporations for knockdown experiments were performed with a scrambled shRNA in the pSuper vector with an empty pCIG2 vector. Control electroporations for <italic>Tubb5</italic> overexpression studies were performed with an empty pCIG2 vector together with an empty pSuper vector. Pregnant dams were sacrificed by cervical dislocation, and the embryonic brains dissected and fixed in 4% PFA in PBS overnight. Following three washes in PBS, the brains were incubated in 20% sucrose/PBS overnight before embedding in optimal cutting temperature compound. Cryosectioning (16Â Î¼m) was performed on a freezing microtome (Leica). Fluorescence immunostaining was performed as previously described (<xref rid="bib7" ref-type="bibr">Heng etÂ al., 2008</xref>), and images were captured on an epifluorescence microscope (Olympus) equipped with a CCD camera (SPOT). Subdivisions of the embryonic cortex (VZ, SVZ, IZ, and CP) were identified based on cell density as visualized with DAPI (4â²6-diamidino-2-phenylindole) staining. Cell counting was performed blind to the condition on representative fields of sections of electroporated brains using ImageJ software. Immunostaining for activated (cleaved) caspase-3 utilized a rabbit polyclonal antibody (AB3623, Merck Millipore) at a 1:1,000 dilution.</p>
            </sec>
            <sec id="dtbox1sec7">
              <title>InÂ Vitro Transcription/Translation Reactions</title>
              <p>Plasmids engineered for the T7-driven expression of wild-type, M299V, V353I, and E401K TUBB5 were used to drive expression in rabbit reticulocyte lysate (Promega) containing <sup>35</sup>S-methionine as described (<xref rid="bib20" ref-type="bibr">Tian etÂ al., 2010</xref>). At various intervals, aliquots were withdrawn and analyzed on native polyacrylamide gels. In some cases, the reactions were supplemented (to a final concentration of 0.2Â mg/ml) with native bovine brain tubulin after 90Â min and the incubation continued for a further 30 or 90Â min.</p>
            </sec>
          </boxed-text>
        </p>
      </sec>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ayala</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Shu</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Tsai</surname>
              <given-names>L.H.</given-names>
            </name>
          </person-group>
          <article-title>Trekking across the brain: the journey of neuronal migration</article-title>
          <source>Cell</source>
          <volume>128</volume>
          <year>2007</year>
          <fpage>29</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="pmid">17218253</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Braun</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Breuss</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Salzer</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Flint</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Cowan</surname>
              <given-names>N.J.</given-names>
            </name>
            <name>
              <surname>Keays</surname>
              <given-names>D.A.</given-names>
            </name>
          </person-group>
          <article-title>Tuba8 is expressed at low levels in the developing mouse and human brain</article-title>
          <source>Am. J. Hum. Genet.</source>
          <volume>86</volume>
          <year>2010</year>
          <fpage>819</fpage>
          <lpage>822</lpage>
          <comment>author reply 822â813</comment>
          <pub-id pub-id-type="pmid">20466094</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cowan</surname>
              <given-names>N.J.</given-names>
            </name>
            <name>
              <surname>Lewis</surname>
              <given-names>S.A.</given-names>
            </name>
          </person-group>
          <article-title>Type II chaperonins, prefoldin, and the tubulin-specific chaperones</article-title>
          <source>Adv. Protein Chem.</source>
          <volume>59</volume>
          <year>2001</year>
          <fpage>73</fpage>
          <lpage>104</lpage>
          <pub-id pub-id-type="pmid">11868281</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edwards</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Treiber</surname>
              <given-names>C.D.</given-names>
            </name>
            <name>
              <surname>Breuss</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Pidsley</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>G.J.</given-names>
            </name>
            <name>
              <surname>Cleak</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Oliver</surname>
              <given-names>P.L.</given-names>
            </name>
            <name>
              <surname>Flint</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Keays</surname>
              <given-names>D.A.</given-names>
            </name>
          </person-group>
          <article-title>Cytoarchitectural disruption of the superior colliculus and an enlarged acoustic startle response in the Tuba1a mutant mouse</article-title>
          <source>Neuroscience</source>
          <volume>195</volume>
          <year>2011</year>
          <fpage>191</fpage>
          <lpage>200</lpage>
          <pub-id pub-id-type="pmid">21875651</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Feng</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Walsh</surname>
              <given-names>C.A.</given-names>
            </name>
          </person-group>
          <article-title>Protein-protein interactions, cytoskeletal regulation and neuronal migration</article-title>
          <source>Nat. Rev. Neurosci.</source>
          <volume>2</volume>
          <year>2001</year>
          <fpage>408</fpage>
          <lpage>416</lpage>
          <pub-id pub-id-type="pmid">11389474</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gloster</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>El-Bizri</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Bamji</surname>
              <given-names>S.X.</given-names>
            </name>
            <name>
              <surname>Rogers</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>F.D.</given-names>
            </name>
          </person-group>
          <article-title>Early induction of Talpha1 alpha-tubulin transcription in neurons of the developing nervous system</article-title>
          <source>J. Comp. Neurol.</source>
          <volume>405</volume>
          <year>1999</year>
          <fpage>45</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="pmid">10022195</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heng</surname>
              <given-names>J.I.</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Castro</surname>
              <given-names>D.S.</given-names>
            </name>
            <name>
              <surname>Zimmer</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Wildner</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Armant</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Skowronska-Krawczyk</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Bedogni</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Matter</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Hevner</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Guillemot</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>Neurogenin 2 controls cortical neuron migration through regulation of Rnd2</article-title>
          <source>Nature</source>
          <volume>455</volume>
          <year>2008</year>
          <fpage>114</fpage>
          <lpage>118</lpage>
          <pub-id pub-id-type="pmid">18690213</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jaglin</surname>
              <given-names>X.H.</given-names>
            </name>
            <name>
              <surname>Poirier</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Saillour</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Buhler</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Bahi-Buisson</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Fallet-Bianco</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Phan-Dinh-Tuy</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Kong</surname>
              <given-names>X.P.</given-names>
            </name>
            <name>
              <surname>Bomont</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Mutations in the beta-tubulin gene TUBB2B result in asymmetrical polymicrogyria</article-title>
          <source>Nat. Genet.</source>
          <volume>41</volume>
          <year>2009</year>
          <fpage>746</fpage>
          <lpage>752</lpage>
          <pub-id pub-id-type="pmid">19465910</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Keays</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Poirier</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>G.J.</given-names>
            </name>
            <name>
              <surname>Siebold</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Cleak</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Oliver</surname>
              <given-names>P.L.</given-names>
            </name>
            <name>
              <surname>Fray</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Harvey</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>MolnÃ¡r</surname>
              <given-names>Z.</given-names>
            </name>
          </person-group>
          <article-title>Mutations in alpha-tubulin cause abnormal neuronal migration in mice and lissencephaly in humans</article-title>
          <source>Cell</source>
          <volume>128</volume>
          <year>2007</year>
          <fpage>45</fpage>
          <lpage>57</lpage>
          <pub-id pub-id-type="pmid">17218254</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>W.Y.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Doble</surname>
              <given-names>B.W.</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Woodgett</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Snider</surname>
              <given-names>W.D.</given-names>
            </name>
          </person-group>
          <article-title>GSK-3 is a master regulator of neural progenitor homeostasis</article-title>
          <source>Nat. Neurosci.</source>
          <volume>12</volume>
          <year>2009</year>
          <fpage>1390</fpage>
          <lpage>1397</lpage>
          <pub-id pub-id-type="pmid">19801986</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kumar</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Pilz</surname>
              <given-names>D.T.</given-names>
            </name>
            <name>
              <surname>Babatz</surname>
              <given-names>T.D.</given-names>
            </name>
            <name>
              <surname>Cushion</surname>
              <given-names>T.D.</given-names>
            </name>
            <name>
              <surname>Harvey</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Topf</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Yates</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Robb</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Uyanik</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Mancini</surname>
              <given-names>G.M.</given-names>
            </name>
          </person-group>
          <article-title>TUBA1A mutations cause wide spectrum lissencephaly (smooth brain) and suggest that multiple neuronal migration pathways converge on alpha tubulins</article-title>
          <source>Hum. Mol. Genet.</source>
          <volume>19</volume>
          <year>2010</year>
          <fpage>2817</fpage>
          <lpage>2827</lpage>
          <pub-id pub-id-type="pmid">20466733</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Geisert</surname>
              <given-names>E.E.</given-names>
            </name>
            <name>
              <surname>Frankfurter</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Spano</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>C.X.</given-names>
            </name>
            <name>
              <surname>Yue</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Dragatsis</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Goldowitz</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>A transgenic mouse class-III beta tubulin reporter using yellow fluorescent protein</article-title>
          <source>Genesis</source>
          <volume>45</volume>
          <year>2007</year>
          <fpage>560</fpage>
          <lpage>569</lpage>
          <pub-id pub-id-type="pmid">17868115</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lizarraga</surname>
              <given-names>S.B.</given-names>
            </name>
            <name>
              <surname>Margossian</surname>
              <given-names>S.P.</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>Campagna</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Blevins</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mudbhary</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Barker</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Walsh</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Fleming</surname>
              <given-names>M.D.</given-names>
            </name>
          </person-group>
          <article-title>Cdk5rap2 regulates centrosome function and chromosome segregation in neuronal progenitors</article-title>
          <source>Development</source>
          <volume>137</volume>
          <year>2010</year>
          <fpage>1907</fpage>
          <lpage>1917</lpage>
          <pub-id pub-id-type="pmid">20460369</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>LÃ¶we</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Downing</surname>
              <given-names>K.H.</given-names>
            </name>
            <name>
              <surname>Nogales</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Refined structure of alpha beta-tubulin at 3.5 A resolution</article-title>
          <source>J. Mol. Biol.</source>
          <volume>313</volume>
          <year>2001</year>
          <fpage>1045</fpage>
          <lpage>1057</lpage>
          <pub-id pub-id-type="pmid">11700061</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Neale</surname>
              <given-names>B.M.</given-names>
            </name>
            <name>
              <surname>Kou</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Maâayan</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Samocha</surname>
              <given-names>K.E.</given-names>
            </name>
            <name>
              <surname>Sabo</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>C.F.</given-names>
            </name>
            <name>
              <surname>Stevens</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L.S.</given-names>
            </name>
            <name>
              <surname>Makarov</surname>
              <given-names>V.</given-names>
            </name>
          </person-group>
          <article-title>Patterns and rates of exonic de novo mutations in autism spectrum disorders</article-title>
          <source>Nature</source>
          <volume>485</volume>
          <year>2012</year>
          <fpage>242</fpage>
          <lpage>245</lpage>
          <pub-id pub-id-type="pmid">22495311</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ohnuma</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>W.A.</given-names>
            </name>
          </person-group>
          <article-title>Neurogenesis and the cell cycle</article-title>
          <source>Neuron</source>
          <volume>40</volume>
          <year>2003</year>
          <fpage>199</fpage>
          <lpage>208</lpage>
          <pub-id pub-id-type="pmid">14556704</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pacary</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Heng</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Azzarelli</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Riou</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Castro</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Lebel-Potter</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Parras</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Bell</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Ridley</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Parsons</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Guillemot</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>Proneural transcription factors regulate different steps of cortical neuron migration through Rnd-mediated inhibition of RhoA signaling</article-title>
          <source>Neuron</source>
          <volume>69</volume>
          <year>2011</year>
          <fpage>1069</fpage>
          <lpage>1084</lpage>
          <pub-id pub-id-type="pmid">21435554</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pinto</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Pagnamenta</surname>
              <given-names>A.T.</given-names>
            </name>
            <name>
              <surname>Klei</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Anney</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Merico</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Regan</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Conroy</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Magalhaes</surname>
              <given-names>T.R.</given-names>
            </name>
            <name>
              <surname>Correia</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Abrahams</surname>
              <given-names>B.S.</given-names>
            </name>
          </person-group>
          <article-title>Functional impact of global rare copy number variation in autism spectrum disorders</article-title>
          <source>Nature</source>
          <volume>466</volume>
          <year>2010</year>
          <fpage>368</fpage>
          <lpage>372</lpage>
          <pub-id pub-id-type="pmid">20531469</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Poirier</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Saillour</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Bahi-Buisson</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Jaglin</surname>
              <given-names>X.H.</given-names>
            </name>
            <name>
              <surname>Fallet-Bianco</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Nabbout</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Castelnau-Ptakhine</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Roubertie</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Attie-Bitach</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Desguerre</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>Mutations in the neuronal Ã-tubulin subunit TUBB3 result in malformation of cortical development and neuronal migration defects</article-title>
          <source>Hum. Mol. Genet.</source>
          <volume>19</volume>
          <year>2010</year>
          <fpage>4462</fpage>
          <lpage>4473</lpage>
          <pub-id pub-id-type="pmid">20829227</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tian</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Jaglin</surname>
              <given-names>X.H.</given-names>
            </name>
            <name>
              <surname>Keays</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Francis</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Chelly</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Cowan</surname>
              <given-names>N.J.</given-names>
            </name>
          </person-group>
          <article-title>Disease-associated mutations in TUBA1A result in a spectrum of defects in the tubulin folding and heterodimer assembly pathway</article-title>
          <source>Hum. Mol. Genet.</source>
          <volume>19</volume>
          <year>2010</year>
          <fpage>3599</fpage>
          <lpage>3613</lpage>
          <pub-id pub-id-type="pmid">20603323</pub-id>
        </element-citation>
      </ref>
      <ref id="bib21">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tischfield</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Baris</surname>
              <given-names>H.N.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Rudolph</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Van Maldergem</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>W.M.</given-names>
            </name>
            <name>
              <surname>Andrews</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Demer</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Robertson</surname>
              <given-names>R.L.</given-names>
            </name>
          </person-group>
          <article-title>Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance</article-title>
          <source>Cell</source>
          <volume>140</volume>
          <year>2010</year>
          <fpage>74</fpage>
          <lpage>87</lpage>
          <pub-id pub-id-type="pmid">20074521</pub-id>
        </element-citation>
      </ref>
      <ref id="bib22">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tischfield</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Cederquist</surname>
              <given-names>G.Y.</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>M.L.</given-names>
              <suffix>Jr.</suffix>
            </name>
            <name>
              <surname>Engle</surname>
              <given-names>E.C.</given-names>
            </name>
          </person-group>
          <article-title>Phenotypic spectrum of the tubulin-related disorders and functional implications of disease-causing mutations</article-title>
          <source>Curr. Opin. Genet. Dev.</source>
          <volume>21</volume>
          <year>2011</year>
          <fpage>286</fpage>
          <lpage>294</lpage>
          <pub-id pub-id-type="pmid">21292473</pub-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walsh</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Engle</surname>
              <given-names>E.C.</given-names>
            </name>
          </person-group>
          <article-title>Allelic diversity in human developmental neurogenetics: insights into biology and disease</article-title>
          <source>Neuron</source>
          <volume>68</volume>
          <year>2010</year>
          <fpage>245</fpage>
          <lpage>253</lpage>
          <pub-id pub-id-type="pmid">20955932</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <ref-list>
      <title>Supplemental References</title>
      <ref id="bib24">
        <mixed-citation publication-type="other">Murtaugh, L.C., Chyung, J.H., and Lassar, A.B. (1999). Sonic hedgehog promotes somitic chondrogenesis by altering the cellular response to BMP signaling. Genes Dev. <italic>13</italic>, 225â237.</mixed-citation>
      </ref>
      <ref id="bib25">
        <mixed-citation publication-type="other">Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., and Speleman, F. (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. <italic>3</italic>, RESEARCH0034.</mixed-citation>
      </ref>
    </ref-list>
    <sec id="app3" sec-type="supplementary-material">
      <title>Supplemental Information</title>
      <p>
        <supplementary-material content-type="local-data" id="mmc1">
          <caption>
            <title>Document S1. Tables S1 and S2</title>
          </caption>
          <media xlink:href="mmc1.pdf"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="mmc2">
          <caption>
            <title>Document S2. Article plus Supplemental Information</title>
          </caption>
          <media xlink:href="mmc2.pdf"/>
        </supplementary-material>
      </p>
    </sec>
    <ack>
      <title>Acknowledgments</title>
      <p>This study was supported by FWF (P21092, P24367) grants to D.A.K, Fondation pour la Recherche MÃ©dicale (Equipe FRM 2007) and ANR (2010Â Blanc 1103 01) grants to J.C., and NIH grants (5R01HD057028 and 5R01GM097376) to N.J.C. J.I.H. is supported by an NH and MRC Career Development Fellowship (ID:1011505). The Australian Regenerative Medicine Institute is supported by grants from the State Government of Victoria and the Australian Government. Thanks to Doug Higgs for access to control DNA samples. D.A.K coordinated and designed this study with J.C. and N.J.C. M.B. and A.B. performed the expression studies. J.I.H., M.B., Y.X., M.H., and Z.Q. performed the inÂ vivo murine experiments. D.A.K., T.G., and K.P. performed the genetic screening and sequencing. K.J.H.R., D.S.R., K.T., and M.B. performed the control sequencing. N.B., S.P., M.M., A.V., and P.G. collected and collated the clinical data. T.C. performed the structural modeling. G.T., X.H.J., and N.J.C. undertook the biochemical studies. M.B. conducted the cellular studies with X.H.J. and L.N. M.B. prepared the figures. D.A.K. and M.B. wrote the manuscript, and all authors commented on it.</p>
    </ack>
    <fn-group>
      <fn id="app1" fn-type="supplementary-material">
        <p>Supplemental Information includes Extended Experimental Procedures, fourÂ figures, and two tables and can be found with this article online at <ext-link ext-link-type="doi" xlink:href="10.1016/j.celrep.2012.11.017">http://dx.doi.org/10.1016/j.celrep.2012.11.017</ext-link>.</p>
      </fn>
      <fn id="app2" fn-type="supplementary-material">
        <p>This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
      </fn>
    </fn-group>
  </back>
  <floats-group>
    <fig id="fig1">
      <label>FigureÂ 1</label>
      <caption>
        <p><italic>Tubb5</italic> Is Highly Expressed in the Developing Mouse and Human Brain</p>
        <p>(A) Relative expression levels of Î²-tubulin genes in the developing mouse brain determined by quantitative real-time PCR at E10.5, E12.5, E14.5, E16.5, and E18.5 and postnatal days zero (P0) and six (P6) (nÂ = 3). Note the early onset and consistently high expression of <italic>Tubb5</italic>.</p>
        <p>(B) Relative expression levels of all the human Î²-tubulin genes in the developing brain at GW13 and GW22.</p>
        <p>(CâH) In situ hybridization results obtained with an antisense probe specific for <italic>Tubb5</italic> at E12.5 (C and D), E14.5 (E and F), and E16.5 (G and H). (D), (F), and (H) show higher magnifications of (C), (E), and (G), respectively. <italic>Tubb5</italic> is detected throughout the developing cortex with strong expression in the preplate at E12.5, and in the SVZ at E14.5.</p>
        <p>(IâX) Antibody staining for Dcx (IâL), Tuj (M-P), Tbr2 (QâT), and Pax6 (UâX) performed on coronal sections of the Tg (Tubb5-EGFP) mouse line at E14.5. GreyÂ scale images of (J), (N), (R), and (V) are shown in (K) and (L), (O) and (P), (S) and (T), and (W) and (X). All markers were found to colocalize with or in GFP-positive cells.</p>
        <p>Scale bars show 500Â Î¼m in (C), (E), and (G); 50Â Î¼m in (D), (F), and (H); 50Â Î¼m in (U); and 10Â Î¼m in (V). Error bars in (A) and (B) show SEM. See also <xref rid="figs1" ref-type="fig">FigureÂ S1</xref>.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>FigureÂ 2</label>
      <caption>
        <p><italic>Tubb5</italic> Depletion Perturbs Progenitor Mitosis and Alters the Positioning of Postmitotic Neurons</p>
        <p>(A) Schematic illustrating the three different in utero electroporation experiments. After electroporation at E14.5, embryos were harvested 36Â hr later to assess the mitotic index, harvested 72Â hr later to assess the migration index, or harvested at P17 to assess the positioning index.</p>
        <p>(B) Quantitation of the mitotic index, showing the relative proportion of GFP positive cells that are also pH3 positive in the VZ and SVZ, IZ, and across all zones (Total) for the following conditions: scrambled shRNA (scrshRNA); shRNA targeting <italic>Tubb5</italic> (shRNA); overexpression of <italic>Tubb5</italic> (pCIG2 <italic>Tubb5</italic>); and the rescue experiment (pCIG2-<italic>Tubb5</italic>Â + shRNA). Note that <italic>Tubb5</italic> depletion results in a significant increase in the mitotic index in comparison to the scrambled control, overexpression, and rescue experiments (n â¥ 5; VZ and SVZ: pÂ &lt; 0.001; Total: pÂ &lt; 0.05).</p>
        <p>(C and D) Representative images for the mitotic index experiment. Arrowheads highlight colocalization of GFP-expressing cells (green) with pH3 staining (red).</p>
        <p>(E and F) Representative images showing the migration assessment following <italic>Tubb5</italic> depletion. Note the conspicuous reduction in the proportion of GFP-positive cells reaching the CP.</p>
        <p>(G) Quantification of the percentage of GFP-positive cells in the VZ, IZ, CP, and marginal zone (MZ) for the migration index following treatment with a scrshRNA; an shRNA targeting <italic>Tubb5</italic> (shRNA); a <italic>Tubb5</italic> expression construct (pCIG2 <italic>Tubb5</italic>); and the rescue experiment (shRNAÂ + pCIG2 <italic>Tubb5</italic>). <italic>Tubb5</italic> depletion results in a moderate but significant increase in the percentage of GFP-positive cells located in the VZ and IZ and a decrease in the percentage of GFP-positive cells in the CP (n â¥ 5, VZ: pÂ &lt; 0.05; IZ: pÂ &lt; 0.05; CP: pÂ &lt; 0.01). This phenotype was partially rescued by coexpression of a <italic>Tubb5</italic> isotype lacking the shRNA targeting sequence (pCIG2 <italic>Tubb5</italic>Â + shRNA). Note that overexpression of <italic>Tubb5</italic> by itself has no effect on migration (pCIG2 <italic>Tubb5</italic>).</p>
        <p>(H) Quantification of the percentage of GFP-positive cells in the six layers of the P17 cortex following treatment with an scrshRNA and a shRNA targeting <italic>Tubb5</italic>.Â <italic>Tubb5</italic> depletion results in a significant increase in the percentage of neurons in layer VI (nÂ = 4; pÂ &lt; 0.05), with a concomitant decrease in layers IIâIV (nÂ = 4; pÂ &lt; 0.01).</p>
        <p>(I and J) Representative images for the positioning index in (H). The red channel shows Cux1 staining in layers IIâIV.</p>
        <p>Scale bars show 50Â Î¼m in (D), 100Â Î¼m in (F), and 200Â Î¼m in (J). Error bars in (B), (G), and (H) show mean Â± SEM.<sup>â</sup>pÂ &lt; 0.05, <sup>ââ</sup>pÂ &lt; 0.01, <sup>âââ</sup>pÂ &lt; 0.001. MZ, marginal zone; scrshRNA, scrambled shRNA. See also <xref rid="figs2" ref-type="fig">FigureÂ S2</xref>.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>FigureÂ 3</label>
      <caption>
        <p>Mutations in <italic>TUBB5</italic> Cause Microcephaly and Affect the Generation of Tubulin Heterodimers in Different Ways</p>
        <p>(AâF) Coronal (A and D), sagittal (B and E), and horizontal (C and F) MRIs of twoÂ patients with <italic>TUBB5</italic>-associated microcephaly (M299V and V353I). (AâC)Â The patient with the M299V mutation has microcephaly (OFC of â2.5 SD), focal polymicrogyria (shown with arrowheads in A), severe brainstem hypoplasia (shown with an arrowhead in B), partial agenesis of the corpus callosum (shown with an arrow in B), and dysmorphic basal ganglia with streaks of white matter (highlighted with an arrowhead in C). (DâF) The patient with the V353I mutation has microcephaly (OFC of â4.0 SD), a hypoplastic corpus callosum (shown with an arrow in E), and a dysmorphic basal ganglia with streaks of white matter running through the lenticular nucleus (shown with an arrowhead in F).</p>
        <p>(G) Structural representation of a tubulin heterodimer highlighting the positions of the mutated residues. The M299 residue is centrally located and is associated with a deep hydrophobic pocket. V353 lies on the intradimer interface, in contrast to E401, which is located at the interdimer interface.</p>
        <p>(HâJ) Higher-resolution images showing the mutated residues within the three-dimensional structure of the tubulin heterodimer. (H) The M299 side chain is surrounded by hydrophobic residues (M267, P305, Y310, F367, shown in green) that could be disrupted by replacement with valine. (J) E401 lies in proximity to a loop (98â104, shown in green) that is critical for the binding of GTP (shown in yellow).</p>
        <p>(K) Denaturing gel of inÂ vitro <sup>35</sup>S-methionine-labeled transcription/translation reaction products for wild-type and TUBB5 mutants showing similar translational efficiencies.</p>
        <p>(L) Kinetic analysis on nondenaturing gels of the products of inÂ vitro transcription/translation reactions for wild-type and TUBB5 mutants. Arrows (top to bottom) denote the migration positions of the chaperonin (CCT)/Î²-tubulin binary complex (CCT/Î²), the TBCD/Î²-tubulin cocomplex, the prefoldin (PFD)/Î²-tubulin binary complex (PFD/Î²), the native tubulin heterodimer (Î±/Î²), and the TBCA/Î²-tubulin cocomplex (TBCA/Î²), each assigned on the basis of their characteristic electrophoretic mobilities. Note that the V353I mutant polypeptide behaved similarly to wild-type controls, whereas there wasÂ a diminished heterodimer yield in the case of M299V and little or no detectable heterodimer in the case of E401K. Note also the absence of TBCA/Î²-tubulin and TBCD/Î²-tubulin cocomplexes and a relatively long persistence of the PFD/Î²-tubulin cocomplex in the case of reactions performed with the E401K mutation. Min. chase indicates that reaction products generated after 90Â min were further chased with added native bovine brain tubulin so as to drive the generation of tubulin heterodimers for the times shown.</p>
        <p>(MâX) Expression of FLAG-tagged wild-type and mutant (M299V, V353I, and E401K) TUBB5 in cultured Neuro-2a cells. Staining with the anti-FLAG antibody is shown in red and the microtubule cytoskeleton visualized using an anti-Î±-tubulin antibody (shown in green). Note that wild-type FLAG-tagged TUBB5, as well as the corresponding M299V and V353I mutants, incorporated into the microtubule lattice (MâO, PâR, and SâU, respectively). This contrasts with the E401K protein, which is distributed throughout the cytoplasm and failed to incorporate into the cytoskeletal network (VâX). Scale bar in (X) is 10Â Î¼m.</p>
        <p>See also <xref rid="figs3" ref-type="fig">FigureÂ S3</xref>.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="fig4">
      <label>FigureÂ 4</label>
      <caption>
        <p>Expression of Disease-Causing <italic>Tubb5</italic> Mutations InÂ Vivo</p>
        <p>(A) Quantification of the mitotic index for cells electroporated with control vectors (ctrl), a <italic>Tubb5</italic> expression vector (pCIG2-<italic>Tubb5</italic>; note that this control is also presented in <xref rid="fig2" ref-type="fig">FigureÂ 2</xref>B), and the mutants identified (pCIG2-<italic>Tubb5</italic>(M299V), pCIG2-<italic>Tubb5</italic>(V353I), pCIG2-<italic>Tubb5</italic>(E401K)). <italic>Tubb5</italic> overexpression resulted in a mitotic index that was comparable to controls. In contrast, there was a large increase in the percentage of GFP-positive cells that are also pH3 positive in the VZ and SVZ when expressing the E401K and V353I mutant constructs (n â¥ 5; E401K and V353I: VZÂ + SVZ: pÂ &lt; 0.001; Total: pÂ &lt; 0.001). This increase in the mitotic index was also apparent when overexpressing the M299V mutation, although the effect was not statistically significant (n â¥ 5; p &gt; 0.05).</p>
        <p>(B) Quantification of the migration index for all five conditions (note that the <italic>Tubb5</italic> overexpression control is also presented in <xref rid="fig2" ref-type="fig">FigureÂ 2</xref>G). Overexpression of theÂ mutants results in an accumulation of GFP-positive cells in the IZ with a concomitant decrease in the CP (nÂ = 5; M299V: IZ: pÂ &lt; 0.001; CP: pÂ &lt; 0.01; V353I: VZ: pÂ &lt; 0.01; IZ: pÂ &lt; 0.001; CP: pÂ &lt; 0.001; E401K: IZ: pÂ &lt; 0.01; CP: pÂ &lt; 0.05) that was not observed when overexpressing <italic>Tubb5</italic> alone (nÂ = 5, p &gt; 0.05).</p>
        <p>(CâE) Representative images used for mitotic index assessment with arrowheads showing colocalization of GFP-expressing cells (green) with pH3 staining (red).</p>
        <p>(FâI) Representative images used for migration assessment. Note the decrease in the relative number of cells reaching the upper layers of the cortex when expressing the mutant constructs in comparison to controls (<sup>â</sup>pÂ &lt; 0.05, <sup>ââ</sup>pÂ &lt; 0.01, <sup>âââ</sup>pÂ &lt; 0.001).</p>
        <p>Scale bars show 50Â Î¼m in (E) and 100Â Î¼m in (I). (A) and (B) show mean Â± SEM. See also <xref rid="figs4" ref-type="fig">FigureÂ S4</xref>.</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
    <fig id="figs1">
      <label>FigureÂ S1</label>
      <caption>
        <p>Negative Controls for <xref rid="fig1" ref-type="fig">FigureÂ 1</xref> and Analysis of the Tg(Tubb5-EGFP) Mouse Line</p>
        <p>(AâC) Negative controls (sense probe) for the inÂ situ hybridization experiments shown in <xref rid="fig1" ref-type="fig">FigureÂ 1</xref> for the indicated time points (E12.5, E14.5, E16.5).</p>
        <p>(DâF) Littermate control of the Tg(Tubb5-EGFP) embryo shown in <xref rid="fig1" ref-type="fig">FigureÂ 1</xref>, negative for the GFP transgene. Images were captured employing the same settings as those shown in (G)-(Q); no background fluorescence can be detected.</p>
        <p>(GâQ) Representative coronal (G, I-K, M-O, Q) and sagittal (H, L, P) sections of Tg(Tubb5-EGFP) embryos at the indicated time points (E12.5, E14.5, E16.5). (I) and (M) show magnifications of the boxed regions shown in (G) and (K). High magnification confocal images of the developing cortex are shown in (J), (N), (Q). Note the robust expression of EGFP throughout the developing cortex, consistent with our inÂ situ studies. Scale bars show 1000Â Î¼m for (AâC), (G), (H), (K), (L), (O) and (P), 500Â Î¼m in (F), 50Â Î¼m for (J), (N) and (Q). DAPI staining (shown in blue) is visible in (G), (H), (K), (L), (O) and (P).</p>
      </caption>
      <graphic xlink:href="figs1"/>
    </fig>
    <fig id="figs2">
      <label>FigureÂ S2</label>
      <caption>
        <p>Supplemental Information to <xref rid="fig2" ref-type="fig">FigureÂ 2</xref> and Assessment of Apoptosis</p>
        <p>(A) Relative expression level of <italic>Tubb5</italic> mRNA in Neuro2a cells following transfection with a pSuper vector driving expression of a shRNA targeted to the 3â² UTR of this gene. This results in a â¼62% knockdown (36Â hr) and â¼77% knockdown (72Â hr) of <italic>Tubb5</italic> mRNA levels. The error bars show the SEM (nÂ = 3 independent experiments for each time point).</p>
        <p>(B and C) Representative images for the assessment of neuronal positioning following electroporation of pCIG2 <italic>Tubb5</italic> and pCIG2 <italic>Tubb5</italic>Â + shRNA.</p>
        <p>(D and E) Representative images for the mitotic index assessment when electroporating with pCIG2 <italic>Tubb5</italic> and pCIG2 <italic>Tubb5</italic>Â + shRNA.</p>
        <p>(FâN) Representative image of the apoptosis experiments showing the GFP channel (F-H), activated caspase-3 staining (I-K) and the merged image (L-N). Boxed regions in F, I and L are shown in the adjacent panels (G, J, M) and (H, K, N). Panels H, K and N highlight the mediodorsal region of the cortex as an internal positive control for caspase-3 staining. The magnified region in H, K and N show an apoptotic cell positive for caspase-3.</p>
        <p>(O) Quantification of GFP+ cells co-localizing with activated capase-3. All conditions show less than 1% of co-localization. An ANOVA followed by a multiple comparison test revealed no significant difference between the relevant experiments (scrshRNA, shRNA, pCIG2 <italic>Tubb5</italic> and pCIG2 <italic>Tubb5</italic>Â + shRNA; ctrl, pCIG2 <italic>Tubb5</italic>, pCIG2 <italic>Tubb5</italic>(M299V), pCIG2 <italic>Tubb5</italic>(V353I) and pCIG2 <italic>Tubb5</italic>(E401K)).</p>
        <p>Scale bars show 50Â Î¼m in (C), 100Â Î¼m in (E), and 200Â Î¼m in (L).</p>
      </caption>
      <graphic xlink:href="figs2"/>
    </fig>
    <fig id="figs3">
      <label>FigureÂ S3</label>
      <caption>
        <p>Supplemental Information to <xref rid="fig3" ref-type="fig">FigureÂ 3</xref></p>
        <p>(AâC) Sequencing traces for patients and parents showing the mutations in <italic>TUBB5</italic> for M299V, V353I, and E401K together with the amino acid conversions. All mutations are de novo. (D) Protein sequence alignment of Î²-tubulins present in humans (upper panel). Note the high conservation between the isoforms for all three loci, with the exception of T299 in TUBB1, the most distinct of the human isoforms. The lower panel shows an alignment of TUBB5 homologs in a variety of species. Note that the three disease causing residues are conserved from yeast to man. (E and F) Horizontal (E) and sagittal (F) MRI images taken at 4Â months of age for the patient harboring the E401K mutation. This individual presented with microcephaly (â4 SD OFC), partial posterior agenesis of the corpus callosum, and dysmorphic basal ganglia.</p>
      </caption>
      <graphic xlink:href="figs3"/>
    </fig>
    <fig id="figs4">
      <label>FigureÂ S4</label>
      <caption>
        <p>Positioning Index following Expression of Mutant Tubb5 InÂ Vivo, Related to <xref rid="fig4" ref-type="fig">FigureÂ 4</xref></p>
        <p>(AâE) Representative images of P17 mouse brains following in utero electroporation at E14.5 with plasmids expressing: (A) scrambled shRNA; (B) <italic>Tubb5</italic> wt; (C) <italic>Tubb5</italic> M299V, (D) <italic>Tubb5</italic> V353I, and (E) <italic>Tubb5</italic> E401K. The cortical regions analyzed are indicated in A. The red channel shows Cux1 staining in layers II-IV. Note the increased number of ectopic cells in deep cortical layers when overexpressing the <italic>Tubb5</italic> mutants (M299V, V353I, E401K).</p>
        <p>(F) Quantification of the percentage of GFP positive cells in layers I-VI of the P17 cortex for all five conditions (note that the control is also presented in <xref rid="fig2" ref-type="fig">FigureÂ 2</xref>H; see also <xref rid="mmc1" ref-type="supplementary-material">Table S2</xref>). Overexpression of the <italic>Tubb5</italic> mutants results in fewer cells in superficial layers of the cortex (M299V; II-IV: pÂ &lt; 0.05, E401K; II-IV: pÂ &lt; 0.001), and an accumulation of GFP positive cells in the deeper layers (E401K; nÂ = 3; VI: pÂ &lt; 0.01), but this was not significant in the case of the V353I mutation (nÂ = 3; p &gt; 0.05). Magnification of the boxed regions in (C), (D), and (E), showing ectopic clusters of GFP positive cells. Note that a number of these cells are also positive for the post-mitotic marker Cux 1. <sup>â</sup>pÂ &lt; 0.05, <sup>ââ</sup>pÂ &lt; 0.01, <sup>âââ</sup>pÂ &lt; 0.001. Data are mean Â± SEM.</p>
        <p>Scale bars show 200Â Î¼m in (E) and 100Â Î¼m in (I).</p>
      </caption>
      <graphic xlink:href="figs4"/>
    </fig>
    <table-wrap id="tbl1" position="float">
      <label>Table 1</label>
      <caption>
        <p>Summary of Clinical, Neurological, Biochemical, Cellular and InÂ Vivo Data Associated with <italic>TUBB5</italic> Mutations</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th/>
            <th>
              <italic>M299V</italic>
            </th>
            <th>
              <italic>V353I</italic>
            </th>
            <th>
              <italic>E401K</italic>
            </th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td>Ethnicity/Origin</td>
            <td>Caucasian</td>
            <td>Sri Lanka</td>
            <td>Vietnam/Caucasian</td>
          </tr>
          <tr>
            <td>Sex</td>
            <td>Male</td>
            <td>Male</td>
            <td>Female</td>
          </tr>
          <tr>
            <td>Age at last evaluation</td>
            <td>2 years 6Â months</td>
            <td>4 years 10Â months</td>
            <td>2 years 8Â months</td>
          </tr>
          <tr>
            <td>OFC at birth</td>
            <td>32Â cm (â3 SD)</td>
            <td>31Â cm (â3 SD)</td>
            <td>28.5Â cm (â4 SD)</td>
          </tr>
          <tr>
            <td>OFC at last evaluation</td>
            <td>â2.5 SD</td>
            <td>46.5Â cm (â4 SD)</td>
            <td>42Â cm (â4 SD)</td>
          </tr>
          <tr>
            <td>Cortical dysgenesis</td>
            <td>Focal polymicrogyria, localized band heterotopia</td>
            <td>None apparent</td>
            <td>None apparent at 4Â months</td>
          </tr>
          <tr>
            <td>Basal ganglia</td>
            <td>Dysmorphic<break/>White matter streaks</td>
            <td>Dysmorphic<break/>White matter streaks</td>
            <td>Dysmorphic</td>
          </tr>
          <tr>
            <td>Cerebellum</td>
            <td>Hypoplastic and dysplastic cerebellar vermis</td>
            <td>Possible white matter abnormalities.</td>
            <td>Large 4th ventricle</td>
          </tr>
          <tr>
            <td>Corpus callosum</td>
            <td>Partial agenesis</td>
            <td>Thin and short but complete</td>
            <td>Partial posterior agenesis</td>
          </tr>
          <tr>
            <td>Cognitive abilities</td>
            <td>Severe MR</td>
            <td>MR (global DQ:48)</td>
            <td>Mild developmental delay</td>
          </tr>
          <tr>
            <td>Verbal abilities</td>
            <td>Severe language delay</td>
            <td>Limited language<break/>Speech delay.</td>
            <td>Delayed</td>
          </tr>
          <tr>
            <td>Motor abilities</td>
            <td>Severe motor delay, ataxia</td>
            <td>Motor delay. Walked at 21Â months.</td>
            <td>Motor delay. Walked at 25Â months</td>
          </tr>
          <tr>
            <td>Other</td>
            <td>Retina dysplasia and micro-ophthalmia</td>
            <td>None apparent.</td>
            <td>Prenatal diagnosis of cardiopathy</td>
          </tr>
          <tr>
            <td>Family history</td>
            <td>None</td>
            <td>Motherâs OFC is â4 SD<break/>Brotherâs OFC is â2 SD<break/>Sisterâs OFC is â1 SD</td>
            <td>None</td>
          </tr>
          <tr>
            <td>Heterodimer folding</td>
            <td>Slightly impaired</td>
            <td>Not affected</td>
            <td>Severely impaired</td>
          </tr>
          <tr>
            <td>Microtubule lattice incorporation</td>
            <td>Not affected</td>
            <td>Not affected</td>
            <td>No incorporation</td>
          </tr>
          <tr>
            <td>Mitotic index</td>
            <td>n.s.</td>
            <td>Significantly increased</td>
            <td>Significantly increased</td>
          </tr>
          <tr>
            <td>Migration index</td>
            <td>Significantly decreased</td>
            <td>Significantly decreased</td>
            <td>Significantly decreased</td>
          </tr>
          <tr>
            <td>Positioning index</td>
            <td>Affected</td>
            <td>n.s.</td>
            <td>Affected</td>
          </tr>
          <tr>
            <td>Ectopic clusters at P17</td>
            <td>Yes</td>
            <td>Yes</td>
            <td>Yes</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p>OFC, orbitofrontal cortex; MR, mental retardation; DQ, development quotient; n.s., nonsignificant.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>

</metadata></record></GetRecord></OAI-PMH>